Owens & Minor Beats Analyst Estimates on EPS

Owens & Minor (NYS: OMI) reported earnings on Feb. 6. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Owens & Minor met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded, and GAAP earnings per share grew.

Gross margins shrank, operating margins expanded, and net margins were steady.

Revenue details
Owens & Minor booked revenue of $2.18 billion. The nine analysts polled by S&P Capital IQ predicted a top line of $2.16 billion. Sales were 6.1% higher than the prior-year quarter's $2.06 billion.


Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.

EPS details
Non-GAAP EPS came in at $0.53. The 10 earnings estimates compiled by S&P Capital IQ anticipated $0.51 per share on the same basis. GAAP EPS of $0.38 for Q3 were 12% higher than the prior-year quarter's $0.34 per share.


Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 9.7%, 130 basis points worse than the prior-year quarter. Operating margin was 2.5%, 40 basis points better than the prior-year quarter. Net margin was 1.1%, about the same as the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $2.19 billion. On the bottom line, the average EPS estimate is $0.47.

Next year's average estimate for revenue is $8.62 billion. The average EPS estimate is $1.91.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 123 members rating the stock outperform and nine members rating it underperform. Among 41 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 38 give Owens & Minor a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Owens & Minor is hold, with an average price target of $29.13.

If you're interested in health care stocks like Owens & Minor, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Click here for instant access to this free report.

At the time this article was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story